Year |
Citation |
Score |
2024 |
Murayama T, Mahadevan NR, Meador CB, Ivanova EV, Pan Y, Knelson EH, Tani T, Nakayama J, Ma X, Thai TC, Hung YP, Kim W, Watanabe H, Cai K, Hata AN, et al. Targeting TREX1 induces innate immune response in drug-resistant Small Cell Lung Cancer. Cancer Research Communications. PMID 39177280 DOI: 10.1158/2767-9764.CRC-24-0360 |
0.43 |
|
2024 |
Tani T, Mathsyaraja H, Campisi M, Li ZH, Haratani K, Fahey CG, Ota K, Mahadevan NR, Shi Y, Saito S, Mizuno K, Thai TC, Sasaki N, Homme M, Yusuf CFB, et al. TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity. Cancer Discovery. PMID 38227896 DOI: 10.1158/2159-8290.CD-23-0700 |
0.498 |
|
2023 |
Li Y, Mahadevan NR, Duplaquet L, Hong D, Durmaz YT, Jones KL, Cho H, Morrow M, Protti A, Poitras MJ, Springer BF, Bronson RT, Gong X, Hui YH, Du J, et al. Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1. Cell Reports. Medicine. 4: 101282. PMID 37992688 DOI: 10.1016/j.xcrm.2023.101282 |
0.308 |
|
2023 |
Gerton TJ, Green A, Campisi M, Chen M, Gjeci I, Mahadevan N, Lee CAA, Mishra R, Vo HV, Haratani K, Li ZH, Hasselblatt KT, Testino B, Connor T, Lian CG, et al. Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells. Cancers. 15. PMID 37627156 DOI: 10.3390/cancers15164128 |
0.389 |
|
2023 |
Zhao W, Kepecs B, Mahadevan NR, Segerstolpe A, Weirather JL, Besson NR, Giotti B, Soong BY, Li C, Vigneau S, Slyper M, Wakiro I, Jane-Valbuena J, Ashenberg O, Rotem A, et al. A cellular and spatial atlas of -associated tissue remodeling in lung adenocarcinoma. Biorxiv : the Preprint Server For Biology. PMID 37425718 DOI: 10.1101/2023.06.28.546977 |
0.471 |
|
2022 |
Kitajima S, Tani T, Springer BF, Campisi M, Osaki T, Haratani K, Chen M, Knelson EH, Mahadevan NR, Ritter J, Yoshida R, Köhler J, Ogino A, Nozawa RS, Sundararaman SK, et al. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer. Cancer Cell. PMID 36150391 DOI: 10.1016/j.ccell.2022.08.015 |
0.319 |
|
2022 |
Sengupta S, Das S, Crespo AC, Cornel AM, Patel AG, Mahadevan NR, Campisi M, Ali AK, Sharma B, Rowe JH, Huang H, Debruyne DN, Cerda ED, Krajewska M, Dries R, et al. Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes. Nature Cancer. PMID 36138189 DOI: 10.1038/s43018-022-00427-5 |
0.401 |
|
2022 |
Ricciuti B, Wang X, Alessi JV, Rizvi H, Mahadevan NR, Li YY, Polio A, Lindsay J, Umeton R, Sinha R, Vokes NI, Recondo G, Lamberti G, Lawrence M, Vaz VR, et al. Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Jama Oncology. PMID 35708671 DOI: 10.1001/jamaoncol.2022.1981 |
0.336 |
|
2022 |
Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, Ozgenc I, Noureddine M, Meisenheimer B, Chen M, Piel B, Spicer N, Obua B, Messier CM, Shannon E, ... Mahadevan NR, et al. Activation of tumor-cell STING primes NK-cell therapy. Cancer Immunology Research. PMID 35678717 DOI: 10.1158/2326-6066.CIR-22-0017 |
0.488 |
|
2021 |
Mahadevan NR, Knelson EH, Wolff JO, Vajdi A, Saigi M, Campisi M, Hong D, Thai TC, Piel B, Han S, Reinhold BB, Duke-Cohan JS, Poitras MJ, Taus LJ, Lizotte PH, et al. Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity. Cancer Discovery. PMID 33707236 DOI: 10.1158/2159-8290.CD-20-0913 |
0.411 |
|
2020 |
Sehgal K, Portell AJ, Ivanova EV, Lizotte PH, Mahadevan NR, Greene JR, Vajdi A, Gurjao C, Teceno T, Taus LJ, Thai TC, Kitajima S, Liu D, Tani T, Noureddine M, et al. Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade. The Journal of Clinical Investigation. PMID 33151910 DOI: 10.1172/JCI135038 |
0.371 |
|
2020 |
Campisi M, Sundararaman SK, Shelton SE, Knelson EH, Mahadevan NR, Yoshida R, Tani T, Ivanova E, Cañadas I, Osaki T, Lee SWL, Thai T, Han S, Piel BP, Gilhooley S, et al. Tumor-Derived cGAMP Regulates Activation of the Vasculature. Frontiers in Immunology. 11: 2090. PMID 33013881 DOI: 10.3389/Fimmu.2020.02090 |
0.608 |
|
2020 |
Campisi M, Sundararaman SK, Shelton SE, Knelson EH, Mahadevan NR, Yoshida R, Tani T, Ivanova E, Cañadas I, Osaki T, Lee SWL, Thai T, Han S, Piel BP, Gilhooley S, et al. Tumor-Derived cGAMP Regulates Activation of the Vasculature Frontiers in Immunology. 11. DOI: 10.3389/fimmu.2020.02090 |
0.339 |
|
2020 |
Saigi M, Yoshida R, Knelson EH, Mahadevan NR, Vajdi A, Cañadas I, Thai TC, Awad MM, Sánchez-Céspedes M, Barbie DA. Abstract 1012: Determinants of immune evasion in MET driven lung cancer Immunology. 80: 1012-1012. DOI: 10.1158/1538-7445.Am2020-1012 |
0.379 |
|
2019 |
Barbie TU, Ritter JL, Zhu Z, Thai TC, Mahadevan NR, Mertins P, Knelson EH, Piel BP, Han S, Jaffe JD, Carr SA, Barbie DA. Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple Negative Breast Cancer. Cancer Research. PMID 31662325 DOI: 10.1158/0008-5472.Can-19-1310 |
0.485 |
|
2017 |
Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, Willert K, Lin JH, Zanetti M. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Science Signaling. 10. PMID 28588081 DOI: 10.1126/Scisignal.Aah7177 |
0.732 |
|
2016 |
Zanetti M, Rodvold JJ, Mahadevan NR. The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells. Oncogene. 35: 269-78. PMID 25893303 DOI: 10.1038/Onc.2015.108 |
0.752 |
|
2015 |
Rodvold JJ, Mahadevan NR, Zanetti M. Immune modulation by ER stress and inflammation in the tumor microenvironment. Cancer Letters. PMID 26525580 DOI: 10.1016/J.Canlet.2015.09.009 |
0.729 |
|
2013 |
Mahadevan NR, Rodvold JJ, Zanetti M. A Janus-faced role of the unfolded protein response in antitumor immunity. Oncoimmunology. 2: e23901. PMID 23762789 DOI: 10.4161/Onci.23901 |
0.642 |
|
2013 |
Mahadevan NR, Zanetti M. Sensing hyperploidy and immune surveillance: a pas-de-deux. Cell Cycle (Georgetown, Tex.). 12: 544-5. PMID 23370385 DOI: 10.4161/Cc.23678 |
0.753 |
|
2013 |
Kumandan S, Mahadevan NR, Chiu K, DeLaney A, Zanetti M. Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway. Cancer Letters. 329: 236-42. PMID 23200669 DOI: 10.1016/J.Canlet.2012.11.014 |
0.65 |
|
2013 |
Rodvold JJ, Hiramatsu N, Chiu KT, Mahadevan NR, Lin J, Zanetti M. Abstract B51: Tumor ER stress transmission to infiltrating myeloid cells in vivo require IRE1alpha and TLR4 Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B51 |
0.734 |
|
2012 |
Mahadevan NR, Anufreichik V, Rodvold JJ, Chiu KT, Sepulveda H, Zanetti M. Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming Plos One. 7. PMID 23272178 DOI: 10.1371/Journal.Pone.0051845 |
0.722 |
|
2012 |
Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, Fitamant J, Bardeesy N, Camargo FD, Guan KL. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29. Nature Cell Biology. 14: 1322-9. PMID 23143395 DOI: 10.1038/Ncb2615 |
0.352 |
|
2012 |
Zanetti M, Mahadevan NR. Cancer. Immune surveillance from chromosomal chaos? Science (New York, N.Y.). 337: 1616-7. PMID 23019639 DOI: 10.1126/Science.1228464 |
0.659 |
|
2012 |
Rodvold JJ, Mahadevan NR, Zanetti M. Lipocalin 2 in cancer: when good immunity goes bad. Cancer Letters. 316: 132-8. PMID 22075378 DOI: 10.1016/J.Canlet.2011.11.002 |
0.703 |
|
2012 |
Kumandan S, Mahadevan NR, DeLaney A, Zanetti M. Abstract A5: Can activation of the UPR lead to Trastuzumab resistance? Clinical Cancer Research. 18: A5-A5. DOI: 10.1158/1078-0432.Mechres-A5 |
0.65 |
|
2011 |
Mahadevan NR, Zanetti M. Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. Journal of Immunology (Baltimore, Md. : 1950). 187: 4403-9. PMID 22013206 DOI: 10.4049/Jimmunol.1101531 |
0.734 |
|
2011 |
Mahadevan NR, Rodvold J, Almanza G, Pérez AF, Wheeler MC, Zanetti M. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. Bmc Cancer. 11: 229. PMID 21649922 DOI: 10.1186/1471-2407-11-229 |
0.694 |
|
2011 |
Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells Proceedings of the National Academy of Sciences of the United States of America. 108: 6561-6566. PMID 21464300 DOI: 10.1073/Pnas.1008942108 |
0.707 |
|
2010 |
Mahadevan NR, Fernandez A, Rodvold JJ, Almanza G, Zanetti M. Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. Journal of Inflammation Research. 3: 99-103. PMID 22096360 DOI: 10.2147/Jir.S11190 |
0.696 |
|
Show low-probability matches. |